In FY 2014 the Ansell sexual wellbeing division sold $213M of...

In FY 2014 the Ansell sexual wellbeing division sold $213M of product. Market research (available from Starpharma) indicates good (80%) market acceptance of the coated condoms. In answer to your question I do not know!

The Ansell figures for Australia are not in their board report, just the global sales. If we assumed 20% Vivagel penetration (pun not intended) then that would be about $40M of which the minimum double digit royalty figure would give Starpharma $4M per annum. If the penetration is as per the market research then one could assume 4 times this.

Ansell has 11.2% of the global condom market. Others (including Yokamoto 9.2%).

But if Vivagel takes off, I would expect the big players will be calling.